Metastatic Non-Small Cell Lung Cancer 2023 UPDATE
Two Onc Docs
00:00
Summary of Immunotherapy in Metastatic Non-Small Cell Lung Cancer
Discussion on the use of immunotherapy as a first and second line treatment for metastatic non-small cell lung cancer, including considerations for PDL1 status, combination therapy, and targeted agents.
Transcript
Play full episode
